Literature DB >> 17031868

Tutorial in biostatistics: competing risks and multi-state models.

H Putter1, M Fiocco, R B Geskus.   

Abstract

Standard survival data measure the time span from some time origin until the occurrence of one type of event. If several types of events occur, a model describing progression to each of these competing risks is needed. Multi-state models generalize competing risks models by also describing transitions to intermediate events. Methods to analyze such models have been developed over the last two decades. Fortunately, most of the analyzes can be performed within the standard statistical packages, but may require some extra effort with respect to data preparation and programming. This tutorial aims to review statistical methods for the analysis of competing risks and multi-state models. Although some conceptual issues are covered, the emphasis is on practical issues like data preparation, estimation of the effect of covariates, and estimation of cumulative incidence functions and state and transition probabilities. Examples of analysis with standard software are shown. Copyright 2006 John Wiley & Sons, Ltd.

Mesh:

Year:  2007        PMID: 17031868     DOI: 10.1002/sim.2712

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  627 in total

1.  Prospective assessment of genetic effects on progression to different stages of age-related macular degeneration using multistate Markov models.

Authors:  Yi Yu; Robyn Reynolds; Bernard Rosner; Mark J Daly; Johanna M Seddon
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-03-21       Impact factor: 4.799

2.  Multiple outcomes associated with the use of metformin and sulphonylureas in type 2 diabetes: a population-based cohort study in Italy.

Authors:  Giovanni Corrao; Silvana Antonietta Romio; Antonella Zambon; Luca Merlino; Emanuele Bosi; Marina Scavini
Journal:  Eur J Clin Pharmacol       Date:  2010-11-19       Impact factor: 2.953

3.  Inference for mutually exclusive competing events through a mixture of generalized gamma distributions.

Authors:  William Checkley; Roy G Brower; Alvaro Muñoz
Journal:  Epidemiology       Date:  2010-07       Impact factor: 4.822

4.  Menopausal hormone therapy and risks of colorectal adenomas and cancers in the French E3N prospective cohort: true associations or bias?

Authors:  Sophie Morois; Agnès Fournier; Françoise Clavel-Chapelon; Sylvie Mesrine; Marie-Christine Boutron-Ruault
Journal:  Eur J Epidemiol       Date:  2012-05-29       Impact factor: 8.082

5.  Application of multi-state models in cancer clinical trials.

Authors:  Jennifer G Le-Rademacher; Ryan A Peterson; Terry M Therneau; Ben L Sanford; Richard M Stone; Sumithra J Mandrekar
Journal:  Clin Trials       Date:  2018-07-23       Impact factor: 2.486

6.  Impact of Comorbidities and Age on Cause-Specific Mortality in Postmenopausal Patients with Breast Cancer.

Authors:  Marloes G M Derks; Cornelis J H van de Velde; Daniele Giardiello; Caroline Seynaeve; Hein Putter; Johan W R Nortier; Luc Y Dirix; Esther Bastiaannet; Johanneke E A Portielje; Gerrit-Jan Liefers
Journal:  Oncologist       Date:  2019-01-03

Review 7.  Addressing the Heterogeneity of Heart Failure in Future Randomized Trials.

Authors:  Annamaria Iorio; Andrea Pozzi; Michele Senni
Journal:  Curr Heart Fail Rep       Date:  2017-06

8.  Impact of comorbidities on overall survival in patients with chronic myeloid leukemia: results of the randomized CML study IV.

Authors:  Susanne Saussele; Marie-Paloma Krauss; Rüdiger Hehlmann; Michael Lauseker; Ulrike Proetel; Lida Kalmanti; Benjamin Hanfstein; Alice Fabarius; Doris Kraemer; Wolfgang E Berdel; Martin Bentz; Peter Staib; Maike de Wit; Martin Wernli; Florian Zettl; Holger F Hebart; Markus Hahn; Jochen Heymanns; Ingo Schmidt-Wolf; Norbert Schmitz; Michael J Eckart; Winfried Gassmann; Andrea Bartholomäus; Antonio Pezzutto; Elisabeth Oppliger Leibundgut; Dominik Heim; Stefan W Krause; Andreas Burchert; Wolf-Karsten Hofmann; Joerg Hasford; Andreas Hochhaus; Markus Pfirrmann; Martin C Müller
Journal:  Blood       Date:  2015-04-27       Impact factor: 22.113

9.  Bayesian path specific frailty models for multi-state survival data with applications.

Authors:  Mário de Castro; Ming-Hui Chen; Yuanye Zhang
Journal:  Biometrics       Date:  2015-03-11       Impact factor: 2.571

10.  Effect of Structured Physical Activity on Overall Burden and Transitions Between States of Major Mobility Disability in Older Persons: Secondary Analysis of a Randomized Trial.

Authors:  Thomas M Gill; Jack M Guralnik; Marco Pahor; Timothy Church; Roger A Fielding; Abby C King; Anthony P Marsh; Anne B Newman; Christine A Pellegrini; Shyh-Huei Chen; Heather G Allore; Michael E Miller
Journal:  Ann Intern Med       Date:  2016-09-27       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.